Cargando…

Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program

AIMS: Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hledík, Michal, Polechová, Jitka, Beiglböck, Mathias, Herdina, Anna Nele, Strassl, Robert, Posch, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320988/
https://www.ncbi.nlm.nih.gov/pubmed/34324553
http://dx.doi.org/10.1371/journal.pone.0255267
_version_ 1783730744730845184
author Hledík, Michal
Polechová, Jitka
Beiglböck, Mathias
Herdina, Anna Nele
Strassl, Robert
Posch, Martin
author_facet Hledík, Michal
Polechová, Jitka
Beiglböck, Mathias
Herdina, Anna Nele
Strassl, Robert
Posch, Martin
author_sort Hledík, Michal
collection PubMed
description AIMS: Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. METHODS: Based on county data from the nationwide tests for SARS-CoV-2 in Slovakia between 31.10.–1.11. 2020 we calculate a lower confidence bound for the specificity. As positive test results were not systematically verified by PCR tests, we base the lower bound on a worst case assumption, assuming all positives to be false positives. RESULTS: 3,625,332 persons from 79 counties were tested. The lowest positivity rate was observed in the county of Rožňava where 100 out of 34307 (0.29%) tests were positive. This implies a test specificity of at least 99.6% (97.5% one-sided lower confidence bound, adjusted for multiplicity). CONCLUSION: The obtained lower bound suggests a higher specificity compared to earlier studies in spite of the underlying worst case assumption and the application in a mass testing setting. The actual specificity is expected to exceed 99.6% if the prevalence in the respective regions was non-negligible at the time of testing. To our knowledge, this estimate constitutes the first bound obtained from large scale practical use of an antigen test.
format Online
Article
Text
id pubmed-8320988
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83209882021-07-31 Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program Hledík, Michal Polechová, Jitka Beiglböck, Mathias Herdina, Anna Nele Strassl, Robert Posch, Martin PLoS One Research Article AIMS: Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. METHODS: Based on county data from the nationwide tests for SARS-CoV-2 in Slovakia between 31.10.–1.11. 2020 we calculate a lower confidence bound for the specificity. As positive test results were not systematically verified by PCR tests, we base the lower bound on a worst case assumption, assuming all positives to be false positives. RESULTS: 3,625,332 persons from 79 counties were tested. The lowest positivity rate was observed in the county of Rožňava where 100 out of 34307 (0.29%) tests were positive. This implies a test specificity of at least 99.6% (97.5% one-sided lower confidence bound, adjusted for multiplicity). CONCLUSION: The obtained lower bound suggests a higher specificity compared to earlier studies in spite of the underlying worst case assumption and the application in a mass testing setting. The actual specificity is expected to exceed 99.6% if the prevalence in the respective regions was non-negligible at the time of testing. To our knowledge, this estimate constitutes the first bound obtained from large scale practical use of an antigen test. Public Library of Science 2021-07-29 /pmc/articles/PMC8320988/ /pubmed/34324553 http://dx.doi.org/10.1371/journal.pone.0255267 Text en © 2021 Hledík et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hledík, Michal
Polechová, Jitka
Beiglböck, Mathias
Herdina, Anna Nele
Strassl, Robert
Posch, Martin
Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
title Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
title_full Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
title_fullStr Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
title_full_unstemmed Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
title_short Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
title_sort analysis of the specificity of a covid-19 antigen test in the slovak mass testing program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320988/
https://www.ncbi.nlm.nih.gov/pubmed/34324553
http://dx.doi.org/10.1371/journal.pone.0255267
work_keys_str_mv AT hledikmichal analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram
AT polechovajitka analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram
AT beiglbockmathias analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram
AT herdinaannanele analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram
AT strasslrobert analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram
AT poschmartin analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram